AldredMJ, AddyM, BaggJ, et al.: Oral health in the terminally ill: A cross-sectional pilot survey. Spec Care Dentist, 1991; 11:59–62.
2.
WilbergP, HjermstadMJ, OttesenS, et al.: Oral health is an important issue in end-of-life cancer care. Support Care Cancer, 2012; 20:3115–3122.
3.
FischerDJ, EpsteinJB, YaoY, et al.: Oral health conditions affect functional and social activities of terminally ill cancer patients. Support Care Cancer, 2014; 22:803–810.
4.
SainiR, MarawarP, SheteS, et al.: Dental expression and role in palliative treatment. Indian J Palliat Care, 2009; 15:26–29.
5.
PauA, CroucherR, MarcenesW, et al.: Development and validation of a dental pain-screening questionnaire. Pain, 2005; 119:75–81.
6.
TreisterNS, VillaA, TompsonL: Overview of mouth care at end of life. In: BrueraE, Givens J (eds): UpToDate. Waltham, MA: UpToDate, 2021.
7.
WardenV, HurleyAC, VolicerL: Development and psychometric evaluation of the Pain Assessment in Advanced Dementia (PAINAD) scale. J Am Med Dir Assoc, 2003; 4:9–15.
8.
EpsteinJB, GorskyM, CabayRJ, et al.: Screening for and diagnosis of oral premalignant lesions and oropharyngeal squamous cell carcinoma: Role of primary care physicians. Can Fam Physician, 2008; 54:870–875.
9.
GearyJL, KinironsMJ, BoydD, et al.: Individualized mouth prop for dental professionals and carers. Int J Paediatr Dent, 2000; 10:71–74.
SandersRD: The trigeminal (V) and facial (VII) cranial nerves: Head and face sensation and movement. Psychiatry (Edgmont), 2010; 7:13–16.
12.
Kayser-JonesJ, BirdWF, PaulSM, et al.: An instrument to assess the oral health status of nursing home residents. Gerontologist, 1995; 35:814–824.
13.
AghaR, MirowskiGW: The art and science of oral examination. Dermatol Ther, 2010; 23:209–219.
14.
LyuX, ZhaoC, YanZM, et al.: Efficacy of nystatin for the treatment of oral candidiasis: A systemic review and meta-analysis. Drug Des Devel Ther, 2016; 10:1161–1171.
15.
EpsteinJB, TrueloveEL, OienH, et al.: Oral topical doxepin rinse: Analgesic effect in patients with oral mucosal pain due to cancer or cancer therapy. Oral Oncol, 2001; 37:632–637.
16.
LeenstraJL, MillerRC, QinR, et al.: Doxepin rinse versus placebo in the treatment of acute oral mucositis pain in patients receiving head and neck radiotherapy with or without chemotherapy: A phase III, randomized, double-blind trial (NCCTG-N09C6 [Alliance]). J Clin Oncol, 2014; 32:1571–1577.
17.
EladS, ChengKKF, LallaRV, et al.: MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer, 2020; 126:4423–4443.
18.
McBrideDR: Management of aphthous ulcers. Am Fam Physician, 2000; 62:149–154.
19.
GreerRO, LindenmuthJE, JuarezT, et al.: A double-blind study of topically applied 5% amlexanox in the treatment of aphthous ulcers. J Oral Maxillofac Surg, 1993; 51:243–249.
20.
MulkBS, ChintamaneniRL, MpvP, et al.: Palliative dental care- a boon for debilitating. J Clin Diagn Res, 2014; 8:ZE01-ZE6.
